Jochen Graff und Sebastian Harder - Info zur Person

(1 - 8 von 11

)

8 - OUCIouci.dntb.gov.ua › ...

ouci.dntb.gov.ua

Novel oral anticoagulants: clinical pharmacology, indications and practical considerations. Sebastian Harder, Jochen Graff. https://doi.org s

Pharmacodynamic profile of antiplatelet agents: marked differences...

www.infona.pl

Jochen Graff Ute Klinkhardt Sebastian Harder. Treść / Zawartość. main.pdf. Abstrakt, słowa kluczowe. Źródło. Twórcy. Bibliografia. Dodatkowe informacje.

Close Relationship between the Platelet Activation Marker CD62 and...

jpet.aspetjournals.org

Jochen Graff, Ute Klinkhardt, Valérie B. Schini-Kerth, Sebastian Harder, Nicole Franz, Steffen Bassus and Carl M. Kirchmaier. Journal of Pharmacology and ...

Pharmacodynamic profile of antiplatelet agents: marked differences ...pubmed.ncbi.nlm.nih.gov › ...

pubmed.ncbi.nlm.nih.gov

Jochen Graff , Ute Klinkhardt, Sebastian Harder. Affiliation. 1 Pharmazentrum frankfurt, Institute for Clinical Pharmacology, University Hospital Frankfurt ...

Effects of the Oral, Direct Factor Xa Inhibitor Semantic Scholarwww.semanticscholar.org › paper › Effects-of-the-O...

www.semanticscholar.org

· ... Jochen Graff and Nils von Hentig and Frank Misselwitz and Dagmar Kubitza and Michael Becka and Hans Klaus Breddin and Sebastian Harder ...

CiteSeerX — Significant effects of tipranavir on platelet aggregation...

citeseerx.ist.psu.edu

... Errors · Monitor Changes. by Jochen Graff , Nils Von Hentig , Karina Kuczka , Carlo Angioni , Peter Gute , Stefan Klauke , Errol Babacan , Sebastian Harder ...